Clinical and Translational Imaging

Papers
(The median citation count of Clinical and Translational Imaging is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation67
Copper-mediated late-stage radiofluorination: five years of impact on preclinical and clinical PET imaging44
Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review40
Breast cancer: initial workup and staging with FDG PET/CT32
The role of 18F-FDG PET for COVID-19 infection: myth versus reality17
Value of chest computed tomography scan in diagnosis of COVID-19; a systematic review and meta-analysis17
SNMMI procedure standard/EANM practice guideline on pediatric [99mTc]Tc-DMSA renal cortical scintigraphy: an update15
89Zr-PET imaging in humans: a systematic review15
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand?14
Deep learning-based auto-segmentation of lung tumor PET/CT scans: a systematic review13
Radiolabelled PSMA PET/CT or PET/MRI in hepatocellular carcinoma (HCC): a systematic review12
Nuclear medicine: a global perspective12
Towards quantitative small-animal imaging on hybrid PET/CT and PET/MRI systems11
Systematic review of lung shunt fraction quantification comparing SPECT/CT and planar scintigraphy for yttrium 90 radioembolization planning11
Artificial intelligence techniques support nuclear medicine modalities to improve the diagnosis of Parkinson’s disease and Parkinsonian syndromes11
The role of 18F-FDG PET/CT radiomics in lymphoma10
18F-FDG PET/MRI in adult sarcomas10
PET findings after COVID-19 vaccination: “Keep Calm and Carry On”10
Radiolabeled fibroblast activation protein inhibitor (FAPI) PET in oncology: has the time come for 18F-fluorodeoxyglucose to think to a well-deserved retirement?10
Dopamine transporter imaging in neurodegenerative movement disorders: PET vs. SPECT10
Ultrasound and shear-wave elastography patterns of COVID-19 mRNA vaccine-related axillary, supra and subclavicular lymphadenopathy9
Surveys on COVID-19 in nuclear medicine: what happened and what we learned8
Brain PET/CT using prostate cancer radiopharmaceutical agents in the evaluation of gliomas8
PET/MR in neuro-oncology: is it ready for prime-time?8
New insight and future perspective of mesothelin-targeted agents in nuclear medicine7
Health technology assessment for PSMA-PET: striving towards a cost-effective management of prostate cancer7
Chest computed tomography as a primary tool in COVID-19 detection: an update meta-analysis7
Global research trends in COVID-19 with MRI and PET/CT: a scoping review with bibliometric and network analyses6
Lean approach to improving performance and efficiency in a nuclear medicine department6
An easy and practical guide for imaging infection/inflammation by [18F]FDG PET/CT6
Accidental diagnosis of COVID-19 pneumonia after 18F FDG PET/CT: a case series6
The role of PET radiomic features in prostate cancer: a systematic review5
Molecular imaging of cardiovascular inflammation and infection in people living with HIV infection5
Clinical applications of receptor-binding radiopharmaceutical 99mTc-Tilmanocept: sentinel node biopsy and beyond5
Diffusion tensor imaging of the roots of the brachial plexus: a systematic review and meta-analysis of normative values5
Androgen deprivation therapy and its modulation of PSMA expression in prostate cancer: mini review and case series of patients studied with sequential [68Ga]-Ga-PSMA-11 PET/CT5
Comparison between 18F-FDG and 18F-NaF PET imaging for assessing bone metastases in breast cancer patients: a literature review5
Humbug in a nuclear medicine department?4
Development of nuclear medicine in Africa4
Impact of PSMA PET on management of biochemical recurrent prostate cancer: a systematic review and meta-analysis of prospective studies4
Metabolic connectivity in Alzheimer’s diseases4
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis4
FDG PET/CT versus somatostatin receptor PET/CT in TENIS syndrome: a systematic review and meta-analysis4
The utilization of positron emission tomography in the evaluation of renal health and disease4
Current role of 18F-FDG-PET in the differential diagnosis of the main forms of dementia3
Clinical application of radioiodinated antibodies: where are we?3
Nuclear imaging for diagnosing fracture-related infection3
Prevalence of physiological uptake in the pancreas on somatostatin receptor-based PET/CT: a systematic review and a meta-analysis3
Pulmonary embolism in coronavirus disease-19 (COVID-19): rational and stepwise use of clinical data and imaging in its diagnosis3
68Ga-PSMA PET/CT and mpMRI for primary lymph node staging of intermediate to high-risk prostate cancer: a systematic review and meta-analysis of diagnostic test accuracy3
PET–CT for staging patients with muscle invasive bladder cancer: is it more than just a fancy tool?3
Prevalence and clinical significance of incidental 18F-FDG uptake in the pituitary3
Thoracic imaging radiomics for staging lung cancer: a systematic review and radiomic quality assessment3
Timing of diuretics in diuresis renography3
Funding of nuclear medicine research and association with citation impact3
Peptide receptor radionuclide therapy for GEP-NET: consolidated knowledge and innovative applications3
Role of [18F]-FDG PET in patients with atypical parkinsonism associated with dementia3
Comprehensive review on design perspective of PET ligands based on β-amyloids, tau and neuroinflammation for diagnostic intervention of Alzheimer’s disease3
A multicenter survey of current practices of 99mTc-methoxy-isobutyl-isonitrile (MIBI) imaging for the diagnosis of thyroid nodules: more standardization is essential3
Head-to-head comparison between 18F-FDG PET/low-dose CT and 18F-FDG PET/contrast-enhanced CT in relapsing ovarian carcinoma: a systematic review and meta-analysis3
0.017585039138794